norm: immunicNAICS 325412 · USno LEI · CIK 0001280776Max severity: Low

Canonical registry

Immunic, Inc.

ent_019e3ea41ef6e028f51edc98ce5f1a9b

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Immunic, Inc.
Normalized: immunic— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001280776
Domain: imux.com

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-04-22
This is a 10-K/A (Amendment No. 1) filed by Immunic, Inc. (NASDAQ: IMUX), a clinical-stage biopharmaceutical company, for fiscal year ended December 31, 2025. The amendment restates Part III (Items 10-14) omitted from the original Form 10-K filed February 26, 2026. The document contains no cybersecurity incident disclosure.